
Evidence Based Guidelines Webinar 201: Exome and Genome Sequencing for Pediatric Patients with Congenital Anomalies or Intellectual Disability
Date of Release: July 27, 2022
Expiration Date: July 31, 2024
Credits offered: CME, NSGC Category 2 (Self-report)
Estimate time of completion: 1 hour per webinar
Course must be completed by the expiration date
Series Information:
The Evidence-Based Guidelines Webinar Series, supported by the National Coordinating Center for the Regional Genetics Networks (NCC) and ACMG, is a two-part webinar series for each of the ACMG Evidence-Based Guidelines that will provide an overview and application of the evidence-based guideline (101) and then provide a deeper-diver into the evidence used to support the recommendation (201).
Session Information:
Exome and Genome Sequencing for Pediatric Patients with Congenital Anomalies or Intellectual Disability, join us for a one-hour webinar that will explore in detail the evidence used in the review process, how the evidence was translated into a recommendation using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) framework, and how the guideline can implemented in genetics and non-genetics practice.
Learning Objectives:
At the conclusion of this session, participants should be able to:
- Explain the general framework used to develop the recommendation.
- Describe two pieces of evidence used to support the recommendation.
- Identify patients that may benefit from exome or genome sequencing and when in the diagnostic workup exome or genome sequencing should be considered.
Target Audience:
Healthcare Providers (genetics providers, non-genetics providers who have attended the 101 webinar, healthcare providers who manage patients with congenital anomalies and/or intellectual disabilities).